Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy
Nutrients · 2023
DOI: 10.3390/nu15132834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Cristina Politi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Physiology (IFC), National Research Council of Italy (CNR), 89124 Reggio Calabria, RC, Italy. Hauptthemen laut MEDLINE: Overweight, Gastrointestinal Microbiome. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Ministry of Enterprises and Made in Italy" (MIMIT, ex MISE), “Ministry of Enterprises and Made in Italy” (MIMIT, ex MISE).
Abstract (Originalsprache)
Although the gut microbiota is known to affect body weight, its relationship with overweight/obesity is unclear. Our aim was to characterize microbiota composition in a cohort from the southernmost area of Italy. We investigated whether an altered gut microbiota could play an etiological role in the pathogenesis of overweight/obesity. A total of 163 healthy adults were enrolled. Microbiome analysis was performed via 16S rRNA gene sequencing. We found significant phylum variations between overweight (N = 88) and normal-weight (N = 75) subjects. Bacteroidetes and Proteobacteria were higher in overweight participants (p = 0.004; p = 0.03), and Firmicutes and Verrucomicrobia were lower (p = 0.02; p = 0.008) compared to normal-weight participants. Additionally, Akkermansia and Bifidobacterium (genus level) were significantly lower in the overweight group, as well as Akkermansia muciniphila at the species level. The Firmicutes/Bacteroidetes ratio (F/B ratio), an index of dysbiosis, was found to be inversely associated with BMI in linear and logistic regression models (p = 0.001; p = 0.005). The association remained statistically significant after adjustment for potential confounders. This cross-sectional study contributes to defining the gut microbiota composition in an adult population living in southern Italy. It confirms the relationship between overweight susceptibility and the dysbiosis status, highlighting the possible etiological role of the F/B ratio in disease susceptibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Physiology (IFC), National Research Council of Italy (CNR), 89124 Reggio Calabria, RC, Italy.
- Medilink S.r.l., Via Parma 36/A, Città Giardino, 96010 Melilli, SR, Italy.
- SB SETEC S.p.A., Via Benedetto Croce 11, Città Giardino, 96010 Melilli, SR, Italy.
- Institute for Biomedical Research and Innovation (IRIB), National Research Council of Italy (CNR), 98164 Messina, ME, Italy.
- Classical Linguistic Studies and Education Department, Kore University of Enna, 94100 Enna, EN, Italy.
ORCID-Profile: Belinda Spoto, Giovanni Pioggia, Alessandra Testa
Förderung
- "Ministry of Enterprises and Made in Italy" (MIMIT, ex MISE)
- “Ministry of Enterprises and Made in Italy” (MIMIT, ex MISE)
Zitieren
APA
Politi, C., Mobrici, M., Parlongo, R. M., Spoto, B., Tripepi, G., Pizzini, P., Cutrupi, S., Franco, D., Tino, R., Farruggio, G., Failla, C., Marino, F., Pioggia, G., & Testa, A. (2023). Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy. Nutrients. https://doi.org/10.3390/nu15132834
Vancouver
Politi C, Mobrici M, Parlongo RM, Spoto B, Tripepi G, Pizzini P, et al. Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy. Nutrients. 2023. doi:10.3390/nu15132834
BibTeX
@article{Politi2023,
author = {Politi, Cristina and Mobrici, Marco and Parlongo, Rosa Maria and Spoto, Belinda and Tripepi, Giovanni and Pizzini, Patrizia and Cutrupi, Sebastiano and Franco, Daniele and Tino, Renato and Farruggio, Giuseppe and Failla, Chiara and Marino, Flavia and Pioggia, Giovanni and Testa, Alessandra},
title = {Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15132834}
}
EUVIMED